RS

Enverus Announces Key Promotions and Hires Within Its Executive Ranks

Retrieved on: 
Wednesday, January 19, 2022
Hellman & Friedman, Brooke, Genstar Capital, Growth, CEO, Leadership, Industry, Marketing, Software as a service, RS, Environment, Business, Milton Gendel, Multimedia, Risk, Risk management, Acquisition, Renewable energy, Management

AUSTIN, Texas, Jan. 19, 2022 /PRNewswire/ --Enverus, the leading energy SaaS and data analytics company, has announced several key executive promotions within its global operation.

Key Points: 
  • AUSTIN, Texas, Jan. 19, 2022 /PRNewswire/ --Enverus, the leading energy SaaS and data analytics company, has announced several key executive promotions within its global operation.
  • Enverus empowers companies to transform the traditional way of making decisions, providing access to world-class intellectual capital, innovative cloud technology and collaborative partnerships.
  • These incredible individuals will help lead Enverus into the next chapter of success as we help shape the future of energy the largest market in the world," said Jeff Hughes, CEO of Enverus.
  • Wilcoxson joined Enverus in 2005 and has served in various sales and leadership roles during his 16-year tenure.

Tata Elxsi delivers another quarter of strong and consistent growth, with revenue growth of 33.2% YoY and PAT growth of 43.5% YoY

Retrieved on: 
Tuesday, January 18, 2022
Cloud, Yoy, IDV, Research, Technology, Connected, IOT, EBITDA, RS, FY, YTD, Quarter, EPD, Growth, CEO, Digital, Health care, Leadership, INR, History, Electronics, Communication, Transport, Virtual reality, Industry, PBT, Artificial intelligence, Company, EPS, Original equipment manufacturer, Internet, Medicine, Software, Engineering, Design, BSE, Animal, Bookkeeping, Distribution (marketing), Video game, Electricity

BANGALORE, India, Jan. 18, 2022 /PRNewswire/ -- Tata Elxsi (BSE: 500408 | NSE: TATAELXSI), amongst the world's leading providers of design-led technology services, announced its results for the third quarter of FY 2021-22 ended December 31, 2021.

Key Points: 
  • The company reported 635.4 Cr of revenue from operations for Q3 FY22, registering a growth of 6.7% QoQ & 33.2%YoY.
  • EBITDA for the quarter grew 14.8% QoQ and 46.8% YoY to 210.8 Cr, while PBT grew 17.1% QoQ and 36.9% YoY to 200.3 Cr.
  • Company's net profit for the quarter stood at Rs 151 Cr, reporting a growth of 20.4% QoQ and 43.5% YoY.
  • Media & Communicationsdelivered another quarter of consistent growth with 6.5% QoQ and 31.1% YoY growth respectively, supported by the addition of marque global customers, and strategic platform and solution-led multi-year deal wins.

Tata Elxsi delivers another quarter of strong and consistent growth, with revenue growth of 33.2% YoY and PAT growth of 43.5% YoY

Retrieved on: 
Tuesday, January 18, 2022
Cloud, Yoy, IDV, Research, Technology, Connected, IOT, EBITDA, RS, FY, YTD, Quarter, EPD, Growth, CEO, Digital, Health care, Leadership, INR, History, Electronics, Communication, Transport, Virtual reality, Industry, PBT, Artificial intelligence, Company, EPS, Original equipment manufacturer, Internet, Medicine, Software, Engineering, Design, BSE, Animal, Bookkeeping, Distribution (marketing), Video game, Electricity

The company reported 635.4 Cr of revenue from operations for Q3 FY22, registering a growth of 6.7% QoQ & 33.2%YoY.

Key Points: 
  • The company reported 635.4 Cr of revenue from operations for Q3 FY22, registering a growth of 6.7% QoQ & 33.2%YoY.
  • EBITDA for the quarter grew 14.8% QoQ and 46.8% YoY to 210.8 Cr, while PBT grew 17.1% QoQ and 36.9% YoY to 200.3 Cr.
  • Company's net profit for the quarter stood at Rs 151 Cr, reporting a growth of 20.4% QoQ and 43.5% YoY.
  • Media & Communicationsdelivered another quarter of consistent growth with 6.5% QoQ and 31.1% YoY growth respectively, supported by the addition of marque global customers, and strategic platform and solution-led multi-year deal wins.

Mullen Automotive Electric Vehicle Program Update

Retrieved on: 
Thursday, January 13, 2022
FIVE, Securities Exchange Act of 1934, Consumer, COVID-19, Technology, International Auto Show, Forward-looking statement, Annual report, Intention, Form 10-K, Max, NASDAQ, CEO, Solution, GLOBE, Kilowatt-hour, Ownership, Time, EV, Industry, Van, Top, Company, RS, Contract, Risk, Engineering, EVS, OTA, BIW, Fireworks, Risk management, Atmosphere of Earth, Mullen, AMEC

(NASDAQ: MULN ) (Mullen or the Company), an emerging electric vehicle (EV) manufacturer, announces today an update for Mullen Shareholders on the Mullen FIVE EV Crossover Program and the Mullen EV Cargo Van Program.

Key Points: 
  • (NASDAQ: MULN ) (Mullen or the Company), an emerging electric vehicle (EV) manufacturer, announces today an update for Mullen Shareholders on the Mullen FIVE EV Crossover Program and the Mullen EV Cargo Van Program.
  • The Mullen engineering team, along with our supplier partners, are making good progress to complete the first fully functional vehicles for both the Mullen FIVE Launch edition and Mullen FIVE RS, high performance edition.
  • Mullen is planning for media and consumer events in late summer and early fall, where existing Mullen FIVE reservation holders and invited media will get to fully experience the vehicle, including test driving the FIVE in person.
  • Mullen also recently announced a string of key partnerships with ARRK, Drr and DSA Systems for automotive engineering, vehicle production systems, and Over the Air (OTA) and vehicle system diagnostics, respectively.

First Sigfox Energy Harvesting Module in Partnership with HT Micron and Nowi

Retrieved on: 
Thursday, January 6, 2022
Software, Mobile, Wireless, Other Energy, Internet, Hardware, Data Management, Alternative Energy, Consumer Electronics, Energy, Technology, Environment, Semiconductor, Other Technology, Hana Micron, HT, Television, CCO, CES, Communication, Ownership, RS, Environment, BOM, Internet, CIO, Power management integrated circuit, Nowy Styl, Partnership, Technology, Computer, Vibration, Multimedia, Solution, R, Micrometre, Light, Consumer electronics, Renewable energy, Video game console, Film, IOT, Sigfox

During the research phase, HT Micron has worked on creating the innovative semiconductor solution to be integrated with Nowis Energy Harvesting PMIC (Power Management Integrated Circuit) designed especially for low power IoT devices.

Key Points: 
  • During the research phase, HT Micron has worked on creating the innovative semiconductor solution to be integrated with Nowis Energy Harvesting PMIC (Power Management Integrated Circuit) designed especially for low power IoT devices.
  • The low power consumption of Sigfox solutions is particularly well suited to being powered by ambient energy harvesting.
  • Next, Sigfox, Nowi and HT Micron will create a mass production module that can be used by any type of device maker.
  • Nowi has developed energy harvesting power management ICs that combine top harvesting performance with the worlds smallest assembly footprint and lowest BOM cost.

Rotiform Announces Technical Partnership with Audi Sport for the 2022 Dakar Rally

Retrieved on: 
Wednesday, January 5, 2022
FEA, Rally, Engineering, TFSI, GT, Dakar Rally, Growth, Element, RS, Motorcycle, HVB, MGU, Checkers and Rally's, Oracle Enterprise Resource Planning Cloud, Audi Sport GmbH, ATV, Partnership, Max Q Motorsports, Ferrari, Multimedia, Rail transport, Audi

IRVINE, Calif., Jan. 5, 2022 /PRNewswire/ -- Wheel Pros' brand, Rotiform, announced today a technical partnership with Audi Sport and their RS Q e-tron alternative-powered vehicle. The innovative prototype vehicle debuted at the 2022 Dakar Rally. The RS Q e-tron is an unprecedented vehicle in its class – not only as a technical concept but marking both Audi and Rotiform's first appearance in the world renowned race.

Key Points: 
  • IRVINE, Calif., Jan. 5, 2022 /PRNewswire/ --Wheel Pros' brand, Rotiform, announced today a technical partnership with Audi Sport and their RS Q e-tron alternative-powered vehicle.
  • The innovative prototype vehicle debuted at the 2022 Dakar Rally.
  • The partnership will include Rotiform race wheels on the factory Audi vehicles, featuring a variety of race-proven design techniques.
  • "As an Audi owner, fan and enthusiast myself, I have dreamed of working alongside Audi race tea,ms.

Lou Holland Jr. Appointed to Adams Street Partners Board of Directors

Retrieved on: 
Tuesday, January 4, 2022
Banking, Professional Services, Finance, Global, Foundation, University, Augustus A. Bird, Oppenheimer, The Guardian Life Insurance Company of America, RS, Nuveen, UBS, CEO, Chair, Marketing, LLC, Board, Security, Board of directors, CFO, Multimedia, Industry, Adams Street Shul, National Science Board, Investment, Leadership, Management, Security (finance), Economics, Director

Adams Street Partners , LLC, a private markets investment management firm with $49 billion in assets under management, today announced that Lou Holland Jr. has joined the firms Board of Directors as its fifth member.

Key Points: 
  • Adams Street Partners , LLC, a private markets investment management firm with $49 billion in assets under management, today announced that Lou Holland Jr. has joined the firms Board of Directors as its fifth member.
  • View the full release here: https://www.businesswire.com/news/home/20220104005242/en/
    Private markets investment manager Adams Street Partners has announced that Lou Holland Jr. has joined the firms Board of Directors as its fifth member.
  • (Photo: Business Wire)
    Lou is a skilled and admired leader and someone whose insight we expect will positively impact Adams Street, said Jeff Diehl, Managing Partner and Head of Investments of Adams Street.
  • Bon French is the Chairman of the Board of Directors and former Managing Partner of Adams Street.

Semtech Unveils SurgeSwitch™ System Transient Protection Product Line, Offering Compelling Performance Advantages Over Conventional TVS Devices

Retrieved on: 
Tuesday, December 21, 2021
Semiconductor, Security, Hardware, Other Technology, Technology, EOS, Goal, TVS, RS, Environment, Financial condition report, Transient voltage suppressor, Algorithm, Atmosphere, Marketing, Architecture, Security (finance), PLC, Power, USB, U.S. Securities and Exchange Commission, Lightning, IEC, Private Securities Litigation Reform Act, Conversation, Internal, ESD, SMTC, Company, Nasdaq, Corporation, IOT, Result, Multimedia, Internet, Engineering, Analysis, Temperature, Transformer, Ethernet, Semtech

Semtechs SurgeSwitch devices are specifically designed to protect circuits and systems operating in harsh industrial and telecom environments.

Key Points: 
  • Semtechs SurgeSwitch devices are specifically designed to protect circuits and systems operating in harsh industrial and telecom environments.
  • Unlike conventional Transient Voltage Suppressor (TVS) diodes, SurgeSwitch devices maintain nearly the same clamping voltage over the entire peak pulse current range and extended temperature range, using an innovative new architecture.
  • Initial SurgeSwitch devices will be available with operating voltages of 22V ( TDS2211P ), 33V ( TDS3311P ), 45V ( TDS4501P ), and 58V ( TDS5801P ).
  • Semtech and the Semtech logo are registered trademarks or service marks, and SurgeSwitch and SClamp are trademarks or service marks, of Semtech Corporation and/or its affiliates.

Vincerx Pharma Announces First Patient Dosed in Phase 1 Dose-Escalation Study of VIP152 in Relapsed or Refractory Chronic Lymphocytic Leukemia or Richter Syndrome

Retrieved on: 
Friday, December 17, 2021
FIH, Forward-looking statement, Failure, MYC, Lists of Transformers characters, Securities Exchange Act of 1934, Drug Quality and Security Act, Mantle cell lymphoma, Nasdaq, Venetoclax, 8-K, Form 10-K, COVID-19, Cancer, Securities Act of 1933, Survival, PALO, Patient, Therapy, DLBCL, Lymphoma, RS, Ovarian cancer, ASH, Chronic lymphocytic leukemia, GLOBE, CDK9, CLL, Pharmaceutical industry, Risk management, Bayer

We are continuing our momentum in the clinic and remain on-track to initiate Phase 2 studies of VIP152 in the second half of 2022.

Key Points: 
  • We are continuing our momentum in the clinic and remain on-track to initiate Phase 2 studies of VIP152 in the second half of 2022.
  • A dose-escalation arm will be performed in R/R CLL before enrolling 20 additional patients in each of the CLL and RS cohorts.
  • The Phase 1 dose-escalation in CLL and RS builds upon Vincerxs ongoing first-in-human (FIH) study ( NCT04978779 ) in patients with advanced cancer, which consists of two expansion arms.
  • Forward-looking statements speak only as of the date hereof, and Vincerx disclaims any obligation to update any forward-looking statements.

Corrected: Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program and Preclinical Data from its ALK2 Inhibitor Program at the 63rd American Society of Hematology Annual Meeting and Exposition

Retrieved on: 
Monday, December 13, 2021
Therapy, Death, Platelet, ALK2, MDS, RBC, TI, Incidence, Haematopoiesis, LTB, KROS, Fatigue, Thrombopoiesis, The Witch: Part 1. The Subversion, Serum, American Society of Hematology, HTB, Research, Inflammation, Solar cycle 1, Nausea, Reticulocyte, Exposition, Disease, RS, Disclosure, Model, GLOBE, Lists of diseases, Acute myeloid leukemia, ASH, Treatment, Breathe Me, Erythropoiesis, Society, Diarrhea, Cohort, Pharmaceutical industry, Medical device, Medical imaging, Residential care, Anemia, Patient, Hematology

LEXINGTON, Mass., Dec. 13, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced that it presented additional data from its ongoing Phase 2 clinical trial of KER-050 in patients with very low-, low-, or intermediate-risk myelodysplastic syndromes (“MDS”), as well as preclinical data on the differentiated mechanism of action of KER-050 and its activity in cytopenia models, at the 63rd American Society of Hematology (“ASH”) Annual Meeting and Exposition, held in person and virtually December 11 through 14, 2021. In addition, Keros announced preclinical data evaluating ALK2 inhibition as a potential treatment option for anemia of inflammation.

Key Points: 
  • In addition, Keros announced preclinical data evaluating ALK2 inhibition as a potential treatment option for anemia of inflammation.
  • We believe these data support the potential of KER-050 as a treatment for multilineage cytopenias in MDS by potentially targeting multiple stages of hematopoiesis.
  • Enrollment was balanced approximately one-to-one between patients that did not have ring sideroblasts (non-RS) and patients that have ring sideroblasts (RS positive).
  • ET, to discuss the additional results from the ongoing Phase 2 clinical trial of KER-050 presented at the 2021 ASH Annual Meeting and Exposition.